PharmaTher Holdings Ltd. PHRM.CN
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · CSE · Canada · pharmather.com
Toronto-based specialty pharmaceutical company focused on personalized medicines, specifically peptides and psychedelics, leveraging its MEDBOTX 3D-printing platform and AI-driven formulation tools for patient-specific dosing and delivery formats. Also trades OTCQB:PHRRF.
Key ratios
ReturnOnAssets TTM -0.59
ReturnOnAssets 2025 -0.48
ReturnOnAssets 2024 -0.43
ReturnOnAssets 2023 -0.27
ReturnOnEquity TTM -1.25
ReturnOnEquity 2025 -0.92
ReturnOnEquity 2024 -0.8
ReturnOnEquity 2023 -0.74
Recent news
PharmaTher Collaborates with Craft Health to Evaluate CraftMake GMP-Ready Pharmaceutical 3D Printing Platform for Personalized Peptides
2026-07-29 · Newsfile
PharmaTher Launches Personaliz3D Peptides to Advance Personalized Peptide Care
2026-07-27 · Newsfile
PharmaTher Enters into Collaboration Agreement for KetaMist(R) to Advance Needle-Free Ketamine Treatment Toward FDA Approval
2026-07-21 · Newsfile
PharmaTher Updates Strategy on Personalized Medicines for Peptides and Psychedelics
2026-07-15 · Newsfile